Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS

被引:106
作者
Konno, Takuya [1 ]
Tada, Masayoshi [1 ]
Tada, Mari [2 ]
Koyama, Akihide [1 ]
Nozaki, Hiroaki [1 ]
Harigaya, Yasuo [5 ]
Nishimiya, Jin [6 ]
Matsunaga, Akiko [7 ]
Yoshikura, Nobuaki [8 ]
Ishihara, Kenji [9 ]
Arakawa, Musashi [1 ]
Isami, Aiko [1 ]
Okazaki, Kenichi [2 ]
Yokoo, Hideaki [10 ]
Itoh, Kyoko [11 ]
Yoneda, Makoto [7 ]
Kawamura, Mitsuru [9 ]
Inuzuka, Takashi [8 ]
Takahashi, Hitoshi [2 ]
Nishizawa, Masatoyo [1 ]
Onodera, Osamu [3 ]
Kakita, Akiyoshi [2 ]
Ikeuchi, Takeshi [1 ,4 ]
机构
[1] Niigata Univ, Dept Neurol, Niigata 95021, Japan
[2] Niigata Univ, Dept Pathol, Niigata 95021, Japan
[3] Niigata Univ, Dept Mol Neurosci, Niigata 95021, Japan
[4] Niigata Univ, Dept Mol Genet, Brain Res Inst, Niigata 95021, Japan
[5] Maebashi Red Cross Hosp, Dept Neurol, Maebashi, Gunma, Japan
[6] Gyotoku Gen Hosp, Dept Neurol, Ichikawa, Japan
[7] Univ Fukui Hosp, Dept Neurol, Fukui, Japan
[8] Gifu Univ, Grad Sch Med, Dept Neurol & Geriatr, Gifu, Japan
[9] Showa Univ, Sch Med, Dept Neurol, Tokyo 142, Japan
[10] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 371, Japan
[11] Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Kyoto 602, Japan
关键词
HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY; ADULT-ONSET LEUKODYSTROPHY; AXONAL SPHEROIDS; NEUROAXONAL SPHEROIDS; PIGMENTARY TYPE; EXPRESSION; MICROGLIA; CELLS; MACROPHAGES; DEFICIENCY;
D O I
10.1212/WNL.0000000000000046
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective:To clarify the genetic, clinicopathologic, and neuroimaging characteristics of patients with hereditary diffuse leukoencephalopathy with spheroids (HDLS) with the colony stimulating factor 1 receptor (CSF-1R) mutation.Methods:We performed molecular genetic analysis of CSF-1R in patients with HDLS. Detailed clinical and neuroimaging findings were retrospectively investigated. Five patients were examined neuropathologically.Results:We found 6 different CSF-1R mutations in 7 index patients from unrelated Japanese families. The CSF-1R mutations included 3 novel mutations and 1 known missense mutation at evolutionarily conserved amino acids, and 1 novel splice-site mutation. We identified a novel frameshift mutation. Reverse transcription PCR analysis revealed that the frameshift mutation causes nonsense-mediated mRNA decay by generating a premature stop codon, suggesting that haploinsufficiency of CSF-1R is sufficient to cause HDLS. Western blot analysis revealed that the expression level of CSF-1R in the brain from the patients was lower than from control subjects. The characteristic MRI findings were the involvement of the white matter and thinning of the corpus callosum with signal alteration, and sequential analysis revealed that the white matter lesions and cerebral atrophy relentlessly progressed with disease duration. Spotty calcifications in the white matter were frequently observed by CT. Neuropathologic analysis revealed that microglia in the brains of the patients demonstrated distinct morphology and distribution.Conclusions:These findings suggest that patients with HDLS, irrespective of mutation type in CSF-1R, show characteristic clinical and neuroimaging features, and that perturbation of CSF-1R signaling by haploinsufficiency may play a role in microglial dysfunction leading to the pathogenesis of HDLS.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 33 条
[1]   A method and server for predicting damaging missense mutations [J].
Adzhubei, Ivan A. ;
Schmidt, Steffen ;
Peshkin, Leonid ;
Ramensky, Vasily E. ;
Gerasimova, Anna ;
Bork, Peer ;
Kondrashov, Alexey S. ;
Sunyaev, Shamil R. .
NATURE METHODS, 2010, 7 (04) :248-249
[2]  
AXELSSON R, 1984, ACTA PSYCHIAT SCAND, V69, P1
[3]   Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred [J].
Baba, Y ;
Ghetti, B ;
Baker, MC ;
Uitti, RJ ;
Hutton, ML ;
Yamaguchi, K ;
Bird, T ;
Lin, WL ;
DeLucia, MW ;
Dickson, DW ;
Wszolek, ZK .
ACTA NEUROPATHOLOGICA, 2006, 111 (04) :300-311
[4]   Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects [J].
Dai, XM ;
Ryan, GR ;
Hapel, AJ ;
Dominguez, MG ;
Russell, RG ;
Kapp, S ;
Sylvestre, V ;
Stanley, ER .
BLOOD, 2002, 99 (01) :111-120
[5]   Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits [J].
Erblich, Bryna ;
Zhu, Liyin ;
Etgen, Anne M. ;
Dobrenis, Kostantin ;
Pollard, Jeffrey W. .
PLOS ONE, 2011, 6 (10)
[6]   Adult Onset Leukodystrophy with Neuroaxonal Spheroids: Clinical, Neuroimaging and Neuropathologic Observations [J].
Freeman, Stefanie H. ;
Hyman, Bradley T. ;
Sims, Katherine B. ;
Hedley-Whyte, E. T. ;
Vossough, Arastoo ;
Frosch, Matthew P. ;
Schmahmann, Jeremy D. .
BRAIN PATHOLOGY, 2009, 19 (01) :39-47
[7]   Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages [J].
Ginhoux, Florent ;
Greter, Melanie ;
Leboeuf, Marylene ;
Nandi, Sayan ;
See, Peter ;
Gokhan, Solen ;
Mehler, Mark F. ;
Conway, Simon J. ;
Ng, Lai Guan ;
Stanley, E. Richard ;
Samokhvalov, Igor M. ;
Merad, Miriam .
SCIENCE, 2010, 330 (6005) :841-845
[8]   PIGMENTARY TYPE OF ORTHOCHROMATIC LEUKODYSTROPHY (OLD) - A NEW CASE WITH ULTRASTRUCTURAL AND BIOCHEMICAL-STUDY [J].
GRAY, F ;
DESTEE, A ;
BOURRE, JM ;
GHERARDI, R ;
KRIVOSIC, I ;
WAROT, P ;
POIRIER, J .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1987, 46 (05) :585-596
[9]   Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections [J].
Hirikoshi, Y ;
Sasaki, A ;
Taguchi, N ;
Maeda, M ;
Tsukagoshi, H ;
Sato, K ;
Yamaguchi, H .
ACTA NEUROPATHOLOGICA, 2003, 105 (02) :157-162
[10]   Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts [J].
Insogna, KL ;
Sahni, M ;
Grey, AB ;
Tanaka, S ;
Horne, WC ;
Neff, L ;
Mitnick, M ;
Levy, JB ;
Baron, R .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2476-2485